Giovanni Frisoni
Nom du groupe: Laboratory of Neuroimaging of Aging
Affiliations: Faculty of Medicine, Geneva University Hospitals, Department of Psychiatry
Domaines: Development and Plasticity
Mot clés: Alzheimer's disease, biomarkers, health care
Activités de recherche
The group has over 20 years of experience in clinical and translational research on Alzheimer’s disease. The main scientific interest is the use of neuroimaging techniques and other biomarkers in persons with or at risk for cognitive impairment. Acquisitions and innovations in fundamental neurosciences, ICT, and technology are uptaken and translated for use into a clinical setting for better pathophysiological understanding, diagnosis, prognosis, disease tracking, drug therapy, and rehabilitation. Specific topics of investigation are: the clinical use of imaging and fluid biomarkers; in vivo neurobiology of Alzheimer’s disease; the clinical use of innovative PET ligands; harmonisation of imaging markers for clinical use; development of innovative image analysis environments based on advanced ICT technology.
Dernières publications
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC.
Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trial.
Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease.
[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study.
Contact
Département de psychiatrie
HUG
Email: Giovanni.Frisoni@hcuge.ch